* Edwards Lifesciences Corp EW.N reported quarterly
adjusted
earnings of 67 cents per share for the quarter ended January
1, higher than the same quarter last year, when the company
reported EPS of 59 cents. The mean expectation of twenty
eight analysts for the quarter was for earnings of 64 cents per
share. Wall Street expected results to range from 54 cents to 70
cents per share.
* Revenue fell 8.5% to $1.35 billion from a year ago;
analysts
expected $1.52 billion.
* Edwards Lifesciences Corp's reported EPS for the quarter
was 61
cents.
* The company reported quarterly net income of $362.1
million.
* Edwards Lifesciences Corp shares had risen by 6.6% this
quarter and lost 7.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 5.3%
in the last three months.
* In the last 30 days, six analysts negatively revised
earnings
estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 14 "strong buy" or "buy," 18
"hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "hold"
Wall Street's median 12-month price target for Edwards
Lifesciences Corp is $75.00
This summary was machine generated from LSEG data October 27 at
03:53 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 0.64 0.67 Beat
Jun. 30 2024 0.69 0.70 Beat
Mar. 31 2024 0.64 0.66 Beat
Dec. 31 2023 0.64 0.64 Met